Short Description

NGS genetic DNA test detecets for variant and mutation detection in CDKN2A gene for Pancreatic cancer/melanoma syndrome, familial

PreTest Information

Clinical History of Patient who is going for CDKN2A Gene Pancreatic cancer/melanoma syndrome, familial NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDKN2A Gene Pancreatic cancer/melanoma syndrome, familial NGS Genetic DNA Test gene CDKN2A

Detail Description

Understanding CDKN2A Gene Pancreatic Cancer/Melanoma Syndrome

CDKN2A gene is responsible for the production of proteins that help regulate cell growth and division. When this gene is mutated, it can lead to an increased risk of developing pancreatic cancer and melanoma. Individuals with a family history of these cancers are at a higher risk of carrying a CDKN2A gene mutation.

Symptoms of CDKN2A Gene Pancreatic Cancer/Melanoma Syndrome

The symptoms of CDKN2A gene pancreatic cancer/melanoma syndrome can vary depending on the type and stage of cancer. Some common symptoms of pancreatic cancer include:

• Jaundice
• Abdominal pain
• Unintended weight loss
• Loss of appetite
• Fatigue

For melanoma, symptoms may include:

• A new, unusual growth or mole on the skin
• A change in the appearance of an existing mole
• Asymmetrical shape or color of the growth or mole
• Irregular borders
• Itchiness or bleeding from the mole or growth

Diagnosis of CDKN2A Gene Pancreatic Cancer/Melanoma Syndrome

Diagnosis of CDKN2A gene pancreatic cancer/melanoma syndrome can be done through genetic testing. This test looks for mutations in the CDKN2A gene that can increase the risk of developing these cancers. Individuals with a family history of pancreatic cancer and/or melanoma should consider genetic testing to determine their risk.

NGS Genetic DNA Test Cost for CDKN2A Gene Pancreatic Cancer/Melanoma Syndrome

The cost of NGS genetic DNA testing for CDKN2A gene pancreatic cancer/melanoma syndrome in India is approximately INR 20,000. This test is highly recommended for individuals with a family history of these cancers, as early detection can lead to better outcomes.

Conclusion

CDKN2A gene pancreatic cancer/melanoma syndrome is a hereditary condition that increases the risk of developing these cancers. Genetic testing can help identify individuals at risk, allowing for early detection and treatment. If you have a family history of pancreatic cancer and/or melanoma, consider getting genetic testing done to determine your risk.

At DNA Labs India, we provide accurate and reliable genetic testing services at an affordable cost. Contact us today to learn more about our services.